What Will Be the Next Emerging Disease Requiring IVDs?

/by Bruce Carlson

Kalorama estimates a $3.7 billion market for emerging diseases. This market is expected to grow to $4.9 billion in 2026. This is based on it’s latest report: Emerging Infectious Disease Market, released August 2022: https://kaloramainformation.com/product/emerging-infectious-disease-diagnostics-markets-and-trends-2022/ In 2015 the World Health Organization held a workshop on prioritization of pathogens “for accelerated R&D for severe emerging diseases […]

Read more

Due to Clinical Laboratory Services, Doctors Can Treat Patients Like Never Before

/by Daniel Granderson

Global clinical laboratory services market is $168 billion and growing, finds new market research report by Kalorama Information Clinical laboratories are an essential part of the health industry, and as a result the global market for clinical laboratory services grew to an estimated $168.3 billion in 2021 (including $79 billion generated from markets outside the […]

Read more

The Middle East and Africa Region a $4 Billion Hotbed for IVD Investment

/by Daniel Granderson

Globally, in vitro diagnostic (IVD) companies are exploring opportunities in developing countries, where rising incomes and standards of living have sparked a new health consciousness and growing demands for quality medical care.  As the COVID-19 dust settles, it is expected that the interest in geographic expansion will once again return to the Middle East and […]

Read more

VIDEO: 5 Key Facts about Point-of-Care (POC) Diagnostic Tests

/0 Comments/by Daniel Granderson

Learn about these 5 key facts based on research featured in The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 9th Edition (published April 2022), a recent report by Kalorama Information Watch the one minute video below for insights and important facts regarding the POC diagnostic testing market. And as always, Kalorama Information offers even more […]

Read more

Point-of-Care (POC) Diagnostic Testing: 5 Key Trends to Watch from 2022-2026

/by Daniel Granderson

Globally, millions of dollars are spent annually on point-of-care (POC) diagnostic testing, both professional testing (which includes physician office labs, clinic labs, employer labs and hospital labs) and self-testing (which includes home, drug store testing and continuous glucose testing).  In 2021, amidst the pandemic, the POC market reached $41,149 million ($41.1 billion) and the market […]

Read more

Pets are Key to $3.5 Billion Veterinary Diagnostic Testing Market

/by Daniel Granderson

“Companion animals (including dogs, cats, and horses) account for 70% of overall market, finds new report by Kalorama Information” – Kalorama Information In the global veterinary diagnostic testing market, the companion animal segment (pets and domestic animals including horses) comprises almost 70% of the $3,540 million ($3.5 billion) overall market, with the food animal segment […]

Read more

Veterinary Diagnostics: COVID-19 Pandemic Can’t Slow Momentum of $3.5 Billion Market

/by Daniel Granderson

  “The veterinary diagnostics market represents a fast-growing opportunity to IVD companies and others able to capitalize on the unfailing need to ensure agricultural productivity and the growth in consumer spending on companion animals.” – Kalorama Information   The veterinary diagnostics market has experienced steady growth through the ravages of the pandemic and is forecast […]

Read more

COVID-19 Diagnostics Market Reaches 32.5BN in 2022. Antigens. Long COVID-19 Driving Spending. Qiagen, Cue Health Other News

/by Bruce Carlson

Hundreds of Tests on The Market, U.S. Labs Mostly Use Ten

As the COVID-19 crisis surfaced in the United States, molecular diagnostic manufacturers went to work with new RT-PCR testing kits.  There have been hundreds of tests on the market receiving EUAs from the Food and Drug Administration, but a survey from the Association of Molecular Pathology demonstrated that only a few are used by laboratories.  As part of its survey: https://www.amp.org/advocacy/sars-cov-2-survey/ labs were asked their top ten testing methods.   Among them: Abbott m2000, Roche cobas were the top two vendors in most labs’ top tens.

Read more

Diagnostics Market to Exceed 80 Billion Dollars in 2020 as Volume of COVID-19 Testing Continues

/by Bruce Carlson

The world market for in vitro diagnostics will reach 83.3 billion dollars in 2020, when the molecular and antibody sales of COVID-19 testing is considered.   This is according to our latest report, The Worldwide Market for In Vitro Diagnostics, 13th Edition, due out August 26th. Molecular diagnostics, for the first time in Kalorama Information’s two-decade […]

Read more

COVID-19 Is Positive and Negative for Digital Pathology

/by Bruce Carlson

Our latest report finds that digital pathology market is 710 million in 2020. The COVID-19 pandemic, while disrupting healthcare in general, also provides a selling point as many pathologists are now at home and need to work digitally. Kalorama Information’s recent study Digital Pathology Markets, 2020-2025, finds a vibrant market that is pushed by the […]

Read more